Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

Vaporized Viral Vector Shows Promise In Anti-Cancer Gene Therapy
A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea.
generic viagra online
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Boston Scientific Corporation (NYSE: BSX) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels. It was approved for use in vessels as small as 2.25 mm in diameter and joins the TAXUS(R) Express(R) Atom(TM) Stent as the only drug-eluting stents approved for small vessel use in the U.S. The Company plans to begin a full U.S. launch of TAXUS Liberte Atom next month.
News of the day
Novel Discovery In Dendritic Cell Signalling Pathways Pave The Way For New Therapeutic Targets
Scientists from A*STAR"s Singapore Immunology Network (SIgN) and the University of Milano-Bicocca, Italy, have discovered another signaling pathway for the activation and apoptosis, or programmed cell death, of dendritic cells[1] . This discovery was published in the advanced online publication of Nature on 15 Jun 2009.
Oncology

First Novel H1N1 Influenza Case Confirmed In Autauga County

The Alabama Department of Public Health has confirmed its first novel H1N1 influenza case in Autauga County. As of June 3, there were 92 confirmed and 8 probable cases of novel H1N1 influenza in the state. Counties and numbers of confirmed novel H1N1 cases which have been reported in their residents are as follows: Madison, 35; Montgomery, 8; Etowah, 8; Coffee, 7; Lee, 7; Jefferson, 5; Shelby, 4; Baldwin, 3; Mobile, 3; Limestone, 2; Pike, 2; Dale, 2; Autauga, 1; Blount, 1; Colbert, 1; and county to be determined, 3. The onset of the patients" symptoms occurred between April 20 and May 26. Approximately half of those affected are under 13 years of age, but the median age of cases has increased to 12 years. The symptoms of novel H1N1 influenza are similar to the symptoms of traditional influenza and include fever, cough, sore throat, body aches, headache, chills and fatigue. Some people have reported diarrhea and vomiting associated with novel H1N1 influenza. Close associates are advised to limit their contact with others for a period of seven days from the time they were exposed. The incubation period from the moment of exposure to novel H1N1 influenza until symptoms develop is two to seven days. Individuals are infectious to others one day before until seven days after symptoms develop. Persons who develop symptoms of respiratory illness should contact their medical provider. The department Web site at http://adph.org/H1N1Flu/ provides regular updates of case counts of novel H1N1 influenza within the state. Alabama Department of Public Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009